Truist Financial Maintains Corcept Therapeutics(CORT.US) With Buy Rating

Moomoo NewsNov 4 07:35 ET · Ratings

Truist Financial Keeps Their Buy Rating on Corcept Therapeutics (CORT)

TipRanksNov 4 07:16 ET · Ratings

Earnings Call: Corcept Therapeutics Reports Robust Q3 Growth, Raises Guidance

InvestingOct 31 13:46 ET

A Quick Look at Today's Ratings for Corcept Therapeutics(CORT.US), With a Forecast Between $67 to $80

Moomoo NewsOct 31 09:00 ET · Ratings

Corcept Therapeutics Incorporated (CORT) Q3 2024 Earnings Call Transcript Summary

moomoo AIOct 30 21:12 ET · Conference Call

Corcept Therapeutics (CORT) Tops Q3 Earnings and Revenue Estimates

Yahoo FinanceOct 30 18:00 ET